PEL

Piramal Enterprises Limited has informed the Exchange regarding a press release dated July 30, 2014, titled, "APG and Piramal Enterprises Limited Announce Strategic Investment Alliance".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated June 05, 2014, titled, "Piramal Enterprises Limited ("PIRAMAL") acquires 9.99% equity stake in Shriram City Union Finance Limited ("SHRIRAM CITY UNION")"

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 05, 2014, titled, "Piramal Enterprises announces Q4FY2014 and full year FY 2014 results; the Board of Directors recommends dividend of Rs. 52.5 per equity share with a total outlay of Rs. 1,059.93 Crores for FY2014.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated April 17, 2014, titled, "Piramal Enterprises Limited ("PIRAMAL") agrees to acquire 20% Equity Stake in Shriram Capital Limited ("SHRIRAM CAPITAL")".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated April 10, 2014 titled "PIRAMAL ENTERPRISES LIMITED ("PIRAMAL") AGREES TO SELL EQUITY STAKE IN VODAFONE INDIA LIMITED".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 30, 2014, titled "Piramal Enterprises announces Q3FY2014 results".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated November 01, 2013, titled "Piramal Enterprises acquires the brand CALADRY(R) in India".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated October 23, 2013, titled "Piramal Enterprises announces Q2FY2014 results".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated July 25, 2013, titled "Piramal Enterprises announces Q1FY2014 results".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 10, 2013, titled "Piramal Enterprises Limited Acquires ~10% Equity Stake in Shriram Transport Finance Company Limited".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 03, 2013, titled "Piramal Enterprises announces Q4 and full year FY2013 result; the Board of Directors has recommended a dividend of Rs. 17.5 per equity share (875%) for FY2013".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 11, 2013, titled "Piramal Enterprises announces Q3 FY2013 result".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated December 03, 2012, titled "Piramal Enterprises' Subsidiary, Decision Resources Group, Acquires Abacus International".

Piramal Enterprises Limited has informed the Exchange regarding a press release dated November 05, 2012, titled "Piramal Enterprises announces Q2 FY2013 result".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated August 14, 2012, titled "Piramal Enterprises announces Q1 FY2013 result".

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated July 20, 2012, titled "Piramal Healthcare's cancer drug P276 moves to Phase II for reduction of serious radiation induced mucositis in patients of head and neck cancer receiving chemoradiation".

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated June 08, 2012 titled "Piramal Healthcare Limited Completes Acquisition of Decision Resources Group."

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 22, 2012, titled "Piramal Healthcare to Present Phase I data for oral anticancer molecule at the American Society for Clinical Oncology (ASCO) Annual Meeting".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 16, 2012, titled "PIRAMAL HEALTHCARE LIMITED TO ACQUIRE DECISION RESOURCES GROUP".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 03, 2012, titled "Piramal Healthcare announces Q4 & full year FY2012 result; Board of Directors has recommended a dividend of Rs.17.5 per equity share (875%) for FY2012, increased dividend reflects confidence in inherent profitability of the Company".

Piramal Healthcare Limited has informed the Exchange regarding a two press releases dated April 16, 2012, titled "Piramal Healthcare Limited acquires molecular imaging development portfolio of Bayer Pharma". and "Encouraging Phase III Study Results Show PET Imaging with Florbetaben Reliably Detects Beta-Amyloid in the Brain".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated April 11, 2012 titled "Piramal Healthcare announces approval of its first innovative product for regenerative medicine, BST-CarGel(R)".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2012 titled "Piramal Healthcare to Acquire Further 5.5% Stake in Vodafone India".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated February 02, 2012 titled "Piramal Healthcare announces Q3FY2012 results, Total operating income up by 16% to Rs 618 crores,Operating Profit was Rs 37 crores and Net Profit for the quarter was Rs 10 crores".

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated November 01, 2011, titled "Piramal Healthcare announces settlement of patent litigation with Baxter Healthcare related to generic version of SUPRANE� (Desflurane)".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated October 20, 2011 , titled "Piramal Healthcare announces Q2FY2012 results, Total operating income up by 32% to Rs 535 crores for continuing businesses, Operating Profit was Rs 130 crores, Net Profit for the quarter was Rs 52 crores".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated August 10, 2011, titled "Piramal Healthcare To Acquire 5.5% Stake in Vodafone Essar".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated August 02, 2011, titled "Piramal Healthcare announces Q1FY2012 results, Total operating income up by 35% to Rs.512 crores for continuing businesses, Operating Profit was higher at Rs.155 crores, Net Profit for the quarter up to Rs.89 crores".

Piramal Healthcare Limited has informed the Exchange regarding Press Releases dated May 06, 2011 titled :" Piramal Healthcare announces Q4FY2011 results, Total operating income up by 62% to Rs. 689 crores, Operating Profit was higher at Rs. 263 crores, Net Profit for the quarter up to Rs. 202 crores" and "Piramal Life Sciences Limited and Piramal Healthcare Limited- Demerger of the NCE Research Unit of Piramal Life Science Limited into Piramal Healthcare Limited"

Piramal Healthcare Limited has informed the Exchange regarding a press release dated February 11, 2011 , titled "Piramal Healthcare announces Q3FY2011 results, Total operating income up by 60% to Rs 534.9 crores for continuing businesses, Operating Profit was higher at Rs 114.1 crores, Net Profit for the quarter up to Rs 60.3 crores."

Piramal Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2010 titled "Piramal Healthcare completes sale of its domestic formulation business and its shareholding in Piramal Diagnostic Services Pvt.Ltd.; PHL to rewards shareholders with buyback of upto 20% of outstanding share capital at Rs.600 per share".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated September 08, 2010, titled "Piramal Healthcare Limited Announces Completion of the Sale of its Domestic Formulations Business to Abbott Healthcare Private Limited".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated August 10, 2010 titled "Piramal Healthcare reports Q1FY2011 results".

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated July 14, 2010 titled "Piramal Healthcare Limited to sell Piramal Diagnostic Services Private Limited to Super Religare Laboratories".

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated June 22, 2010 titled "Piramal Healthcare Limited to acquire assets of BioSyntech, a biotechnology company developing novel products in regenerative medicine".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 21, 2010, titled "Piramal Healthcare Limited to sell its Domestic Formulations (Healthcare Solutions) business to Abbott Laboratories".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 07, 2010, titled "Piramal Healthcare reports FY2010 results; Consolidated Revenues for the year up by 11.9% to Rs. 36.7 billion, Operating Profit up by 27.5% to Rs. 7.4 billion, Net Profit up by 52.4% to Rs. 4.8 billion; Board of Directors has recommended a dividend of Rs. 5.4 per equity share of Rs. 2 (i.e. 270%)".

Piramal Healthcare Limited has informed the Exchange regarding a press release dated April 22, 2010, titled "Piramal Healthcare Limited to acquire the Anesthetic products business of Bharat Serums And Vaccines Limited". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/pirhealth_pr_22042010.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated March 23, 2010, titled "Piramal Healthcare Limited Acquires 'i-pill', India's No 1 Emergency Contraceptive Brand from Cipla Ltd.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/pirhealth_pr_23032010.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 21, 2010, titled "Piramal Healthcare Reports Q3 FY2010 Results; Consolidated Revenues for the quarter up by 9.0% to Rs. 9.1 billion, Operating Profit up by 45.0% to Rs.1.8 billion, Net Profit up by 128% to Rs.1.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_21012010.zip target=NEW> For more details click here

Piramal Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2009, titled "Piramal Healthcare Reports Q2 FY2010 Results; Consolidated Revenues for the Quarter up by 12.4% to Rs. 10.0 billion, Operating Profit up by 26.1% to Rs.1.8 billion, Net Profit up by 44.8% to Rs.1.0 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramil_PR_22102009.zip target=NEW> For more details click h

Piramal Healthcare Limited has informed the Exchange regarding a press release dated July 22, 2009, titled "Piramal Healthcare Reports Q1 FY2010 Results; Consolidated Revenues up for the Quarter by 16.0% to Rs. 8.2 billion, Operating Profit up by 34.0% to Rs.1.6 billion, Net Profit up by 25.0% to Rs.851.0 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_22072009.zip target=NEW> For more details click her

Piramal Healthcare Limited has informed the Exchange regarding a press release dated April 24, 2009, titled "Revenues for FY2009 up by 14.4% to Rs.32.8 billion, EBITDA (excluding FOREX impact) for the year was up by 23.7% at Rs.6.7 billion and Net Profit (excluding FOREX impact) was up by 23.5% to Rs 4.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_24042009.zip target=NEW> For more details click here

Piramal Healthcare Limited has informed the Exchange regarding a press release dated February 28, 2009 titled "Piramal Healthcare Limited Completes Acquisition of Minrad International, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_02032009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 28, 2009, titled "Piramal Healthcare Limited Acquires U.S. Inhalation Anesthetic Gas Distribution Business of RxElite, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_28012009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 22, 2009, titled "Piramal Healthcare reports Q3 FY2009 results; Consolidated revenues for the quarter up by 14.9% to Rs. 8.3 billion, Operating profit (excluding FOREX impact) up by 40.6% to Rs. 1.6 billion, Net Profit (before FOREX impact) up by 29.3% to Rs. 918.9 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_P

Piramal Healthcare Limited has informed the Exchange regarding a press release dated December 23, 2008, titled "Piramal Healthcare Limited to acquire Minrad International, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_23122008.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding the press release dated October 22, 2008, titled "Piramal Healthcare reports Q2 FY2009 results; Consolidated Revenues for the quarter up by 17% to Rs.8.9 billion, Operating Profit (excluding FOREX impact) up by 41% to Rs.1.8 billion, Net Profit (before FOREX impact and exceptional items) up by 40% to Rs.1.2 billion�. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corpo

Piramal Healthcare Limited has informed the Exchange regarding a press release dated July 24, 2008, titled "Piramal Healthcare reports Q1 FY2009 results; Consolidated Revenues up for the Quarter by 17% to Rs. 7.1 billion, Operating Profit up by 42% to Rs. 1.2 billion, Net Profit up by 57% to Rs. 681 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_24072008.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated July 22, 2008, titled "Piramal Healthcare launches French dermo-cosmetic range from Pierre Fabre; Ducray range to re-define care for Indian skin". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_Pr_22072008.zip target=NEW> For more details click here.</a>